Synthetic fibrinolytic agents. 2. Selected N-monosubstituted bis(tetrahydroisoquinolines) designed to possess enhanced bioavailability. 1974

R L Buchanan, and V Sprancmanis, and T A Jenks, and R R Crenshaw, and G M Luke

UI MeSH Term Description Entries
D007546 Isoquinolines A group of compounds with the heterocyclic ring structure of benzo(c)pyridine. The ring structure is characteristic of the group of opium alkaloids such as papaverine. (From Stedman, 25th ed)
D008297 Male Males
D011409 Propylene Glycols Derivatives of propylene glycol (1,2-propanediol). They are used as humectants and solvents in pharmaceutical preparations. Propanediols,Glycols, Propylene
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D005343 Fibrinolytic Agents Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. Antithrombic Drug,Antithrombotic Agent,Antithrombotic Agents,Fibrinolytic Agent,Fibrinolytic Drug,Thrombolytic Agent,Thrombolytic Agents,Thrombolytic Drug,Antithrombic Drugs,Fibrinolytic Drugs,Thrombolytic Drugs,Agent, Antithrombotic,Agent, Fibrinolytic,Agent, Thrombolytic,Agents, Antithrombotic,Drug, Antithrombic,Drug, Fibrinolytic,Drug, Thrombolytic,Drugs, Antithrombic
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

R L Buchanan, and V Sprancmanis, and T A Jenks, and R R Crenshaw, and G M Luke
July 1971, Journal of medicinal chemistry,
R L Buchanan, and V Sprancmanis, and T A Jenks, and R R Crenshaw, and G M Luke
January 1979, Progress in cardiovascular diseases,
R L Buchanan, and V Sprancmanis, and T A Jenks, and R R Crenshaw, and G M Luke
January 2019, ACS chemical neuroscience,
R L Buchanan, and V Sprancmanis, and T A Jenks, and R R Crenshaw, and G M Luke
February 1976, Journal of medicinal chemistry,
R L Buchanan, and V Sprancmanis, and T A Jenks, and R R Crenshaw, and G M Luke
August 2009, Molecules (Basel, Switzerland),
R L Buchanan, and V Sprancmanis, and T A Jenks, and R R Crenshaw, and G M Luke
July 1975, Journal of pharmaceutical sciences,
R L Buchanan, and V Sprancmanis, and T A Jenks, and R R Crenshaw, and G M Luke
May 1967, Journal of medicinal chemistry,
R L Buchanan, and V Sprancmanis, and T A Jenks, and R R Crenshaw, and G M Luke
January 1969, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
R L Buchanan, and V Sprancmanis, and T A Jenks, and R R Crenshaw, and G M Luke
January 1964, Journal of medicinal chemistry,
R L Buchanan, and V Sprancmanis, and T A Jenks, and R R Crenshaw, and G M Luke
May 1969, Journal of medicinal chemistry,
Copied contents to your clipboard!